November 25, 2019   What AAO attendees learned from a single session devoted to diabetes At Retina Subspecialty Day during the 2019 AAO meeting, presentations as varied as artificial intelligence, news from the Diabetic Retinopathy Clinical Research Retina Network (DRCR.net), using OCT to predict visual outcomes, and how to manage patients with high-risk nonproliferative diabetic retinopathy without DME were among the highlights. Learn more ADVERTISEMENT   AMD risk phenotypes targeted in direct-to-consumer genetic database Genetic testing can identify patients with high-risk genotypes for age-related macular degeneration, says Theodore Leng, MD, MS. Learn more ADVERTISEMENT Focusing the battle against dry AMD Andreas F. Borkenstein, MD, discusses a unique device in the fight against dry age-related macular degeneration. Find out RELATED ARTICLES   Guidelines for treating the diabetic eye patient Anti-VEGF injections + glaucoma: Surgeons must watch IOP elevation Risk factors and recommendations for DR, DME Anti-VEGFs pose no additional risk of SAEs over other therapies